false
Catalog
Updates in Proper Use and Administration of Long-A ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
The document provides information on proper use and administration of long-acting injectable antipsychotics (LAIs) for the treatment of serious mental illnesses. It discusses the different types of LAIs available, the indications for use, and the recommended dosing strategies and administration techniques for each medication. It also highlights the importance of preventing medication errors associated with prescribing, dispensing, preparation, and administration of LAIs. The document emphasizes the need for healthcare professionals to be knowledgeable about the specific characteristics of each LAI, such as the route of administration, needle size, and injection site, in order to ensure safe and effective use. Furthermore, it mentions the occurrence of post-injection delirium/sedation syndrome (PDSS) with olanzapine pamoate and the importance of adherence to the Risk Evaluation and Mitigation Strategy (REMS) program for this medication. Overall, the document aims to raise awareness about best practices in the use and administration of LAIs to improve patient outcomes and minimize medication errors.
Keywords
long-acting injectable antipsychotics
LAIs
treatment
serious mental illnesses
medication errors
healthcare professionals
specific characteristics
post-injection delirium/sedation syndrome
olanzapine pamoate
Risk Evaluation and Mitigation Strategy
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English